Published in Int J Cancer on December 19, 1997
Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma. World J Surg (2007) 1.23
Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. J Clin Pathol (2005) 1.06
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer (2008) 1.06
Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res (2010) 0.99
Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients. Int J Oncol (2011) 0.88
CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci (2005) 0.84
Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma. Diagn Pathol (2014) 0.82
Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients. World J Gastroenterol (2006) 0.79
The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key? J Cancer Res Clin Oncol (2012) 0.78
Pivotal molecules of MHC I pathway in human primary hepatocellular carcinoma. World J Gastroenterol (2005) 0.78
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med (2000) 6.98
Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis Rheum (2008) 4.15
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci U S A (1999) 3.74
In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood (2000) 3.57
A better model of acute pancreatitis for evaluating therapy. Ann Surg (1992) 2.81
Ethics of liver transplantation with living donors. N Engl J Med (1989) 2.47
Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol (1997) 2.28
Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment? Endoscopy (2012) 2.18
Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst (1993) 2.14
Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med (1997) 2.03
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol (2000) 1.99
Clinical epidemiology of testicular germ cell tumors. World J Urol (2004) 1.92
Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology (1989) 1.84
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy (1999) 1.83
Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA (2001) 1.81
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg (2009) 1.78
Heterotopic pancreas--clinical presentation and pathology with review of the literature. Hepatogastroenterology (2004) 1.77
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med (2001) 1.74
Pupil evaluation in addition to Glasgow Coma Scale components in prediction of traumatic brain injury and mortality. Br J Surg (2012) 1.73
Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol (2001) 1.67
The ethical assessment of innovative therapies: liver transplantation using living donors. Theor Med (1990) 1.67
Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting. Ann Surg (1990) 1.64
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis (1989) 1.64
p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene (1993) 1.62
Increased utilization of organ donors: transplantation of two recipients from single donor livers. Transplant Proc (1990) 1.61
In situ splitting of the liver in the heart-beating cadaveric organ donor for transplantation in two recipients. Transplantation (1995) 1.61
Long-term outcome and quality of life after thymectomy for myasthenia gravis. Ann Surg (1996) 1.58
Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol (1995) 1.54
Hemostasis with the ultrasonically activated scalpel. Effective substitute for electrocautery in surgical patients with pacemakers. Surg Endosc (1999) 1.51
In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg (1996) 1.50
Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg (1998) 1.50
Quality of life in chronic pancreatitis--results after duodenum-preserving resection of the head of the pancreas. Pancreas (1995) 1.49
[Is the stapled suture in visceral surgery still justified? A prospective controlled, randomized study of cost effectiveness of manual and stapler suture]. Chirurg (1998) 1.49
ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res (2001) 1.48
EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol (2004) 1.47
Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction. Br J Surg (2012) 1.46
p53 in non-small-cell lung cancer. J Natl Cancer Inst (1994) 1.46
From living related to in-situ split liver transplantation: how to reduce waiting-list mortality. Pediatr Transplant (2001) 1.45
Equipoise and the ethics of segmental liver transplantation. Clin Res (1988) 1.44
Hemobilia: presentation, diagnosis, and management. Am J Gastroenterol (1994) 1.43
Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis. A prospective, randomized trial. Ann Surg (1995) 1.43
Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Cancer Res (1999) 1.43
Hilar traumatic neuroma after liver transplantation. Transpl Int (1997) 1.41
The impact of television on attitudes towards organ donation--a survey in a German urban population sample. Nephrol Dial Transplant (1999) 1.40
Systemic effects and side effects of interstitial techniques used in liver tissue. J Am Coll Surg (1999) 1.39
The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies. Am J Respir Crit Care Med (2000) 1.36
Liver transplantation in the management of fulminant hepatic failure. Gastroenterology (1989) 1.35
MAGE-A gene expression pattern in primary breast cancer. Cancer Res (2001) 1.34
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer (2008) 1.34
Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother (1994) 1.34
Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer (1999) 1.33
Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer (1991) 1.31
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br J Cancer (2008) 1.29
The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature. Cancer (1997) 1.28
Reconstruction of the hepatic vein in reduced size hepatic transplantation. Surg Gynecol Obstet (1993) 1.26
Biliary anastomosis in living related liver transplantation using the right liver lobe: techniques and complications. Liver Transpl (2000) 1.22
Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol (1996) 1.22
Biliary complications in pediatric liver transplantation. A comparison of reduced-size and whole grafts. Transplantation (1992) 1.20
Management of concomitant hepatic artery injury in patients with iatrogenic major bile duct injury after laparoscopic cholecystectomy. Br J Surg (2008) 1.18
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol (1994) 1.18
RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci (2000) 1.16
Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg (1994) 1.15
Randomized comparative long-term survival study of endoscopic and thoracoscopic esophageal wall repair after NOTES mediastinoscopy in healthy and compromised animals. Endoscopy (2010) 1.15
A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol (2001) 1.13
Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases. Eur J Med Res (2007) 1.13
Living donor for liver transplantation. Hepatology (1994) 1.11
Living related liver transplantation: 36 cases at the University of Hamburg. Transplant Proc (1994) 1.10
Small-bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med (1990) 1.10
Accurate diagnosis of acute appendicitis: a retrospective and prospective analysis of 686 patients. Eur J Surg (1992) 1.09
Surgical treatment of chronic pancreatitis and quality of life after operation. Surg Clin North Am (1999) 1.08
Choledochocholedochostomy without a T tube or internal stent in transplantation of the liver. Surg Gynecol Obstet (1990) 1.06
Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression. Br J Cancer (2010) 1.06